TABLE 1.
LncRNAs and their effects in T2D
LncRNA | LncRNA origin | Experimental species | Possible molecular mechanisms | Ref. |
---|---|---|---|---|
β cell related | ||||
HI‐LNC25/HI‐LNC78/HI‐LNC80 | Pancreatic islet tissue | Human | Target islet transcription factor GLIS3 | 17 |
β‐linc 1 | Pancreatic islet tissue | Human | Affect endocrine cell differentiation | 18 |
H19 | Pancreatic islet tissue | T2D mice/Rat β cells | Promote β cell proliferation via let‐7/AKT | 19 |
Adipose development related | ||||
BATE1/Blnc1 | BAT | Mice | Promote brown and beige adipocyte differentiation | 20 |
Blnc1 | BAT | Mice | Promote mitochondrial biogenesis | 21 |
LINC00473 | BAT progenitor cells | Human | Regulate mitochondrial oxidative metabolism | 22 |
Adi | ADSCs | Rats | Promote adipogenesis via targeting miR‐499 | 23 |
Dio3os | Fetal BAT from maternal obesity | Mice | Inhibit brown adipose development via maternally imprinted | 24 |
Glucose homeostasis related | ||||
H19 | Livers of db/db mice | Mice | Inhibit gluconeogenesis via Foxo1 | 25 |
Bhmt‐AS | Livers of db/db mice | Mice | Promote gluconeogenesis | 26 |
lncSHGL | Livers | Mice | Inhibit gluconeogenesis via interacting with hnRNPA1 | 27 |
Different expressed‐144 lncRNAs | C2C12 skeletal muscle cells | FFA induced insulin resistant cells | Associated with FAO metabolism and insulin signaling | 28 |
Different expressed‐401 lncRNAs | Skeletal muscles | Rats | Associated with mRNA that regulate glucose metabolism | 29 |
H19 | Skeletal muscles | Rats | Promote glucose metabolism via DUSP27/AMPK | 30 |
H19 | Primary satellite cells isolated from muscles | Mice | Promote FAO gene expressions via interacting with hnRNPA1 | 31 |
Inflammatory related | ||||
LYPLAL1‐DT | Leukocytes | Human umbilical vein endothelial cells | Inhibit inflammation via miR‐204‐5p/SIRT1 | 32 |
Linc‐Gm4419 | Renal tissue/Mesangial cells | Mice/HG treated cells | Promote inflammation via NLRP3 | 33 |
MALAT1 | Brain tissue | Human T2D with OSA | Promote inflammation via miR‐224‐5p/NLRP3 | 34 |
MALAT1 | Peripheral blood mononuclear cells | NA | Promote inflammation via miR‐1‐3p | 35 |
SNHG5 | Serum/HK2 cells | Human/HG treated HK2 cells | Promote inflammation via miR‐224‐5p | 36 |
H19 | Retinal epithelial cells | HG treated retinal epithelial cells | Inhibit inflammation via miR‐93/XBP1 | 37 |
Lnc uc.48 | Serum/Macrophages | Human/HG and FFA treated cells | Promote inflammation via P2X7R/ERK | 38 |
Dnm3Os | BMDM | Mice | Promote inflammatory gene expressions via global histone modifications | 39 |
DRAIR | Monocytes | Human | Inhibit inflammation via epigenetic mechanisms | 40 |
MIST | Adipose macrophages | Mice | Inhibit inflammation via interacting with PARP‐1 | 41 |
Tcons_00077866 | Pancreatic β‐TC6 cells | Mice | Promote inflammation via miR‐297b‐5p/SAA3 | 42 |
Abbreviations: ADSCs, adipose derived stromal cells; BAT, brown adipose tissue; BMDM, bone marrow derived macrophages; FFA, fatty acid; HG, high glucose; OSA, obstructive sleep apnea; T2D, type 2 diabetes.